Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Entegris opens Life Sciences Technology Center in Massachusetts

By Sean Whooley | May 24, 2022

Entegris logoEntegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts.

The new facility was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market, according to a news release.

Entegris’ tools and technologies will be brought together at the laboratory space, and customers can test equipment for freeze and thaw processes to determine which products best fit their needs.

The company said it is now offering Aramus-shaped 2D single-use bags with custom shapes, sizes and assembly configurations for customers’ space and function requirements as part of its manufacturing challenges solutions. They have been designed to be resistant to extreme cold temperatures and to withstand gamma sterilization, making them an option for freezing, transporting, storing and thawing drug substances like COVID-19 vaccines, cell therapies and gene therapies.

“Maintaining product quality, process robustness, reliability and safety is critical for any pharmaceutical product, but novel treatments such as mRNA, gene and cell therapies often require a more intensive approach to their preparation, storage and shipping,” Entegris VP of Life Sciences John Lynch said in the news release. “Building on the success of our Aramus bag assembles and support in COVID-19 vaccine delivery, we have opened the Entegris Life Sciences Technology Center as part of our commitment to enable biopharmaceutical companies to have the technologies and processes in place to provide life-sustaining and life-improving innovations for people around the world, now and in the future.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE